Evidence map›Paper›PMID 37253720›Full record

ArticleTranslational psychiatry2023

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment.

Sameer Jauhar, Robert A McCutcheon, Mattia Veronese, Faith Borgan, Matthew Nour, Maria Rogdaki, Fiona Pepper, James M Stone, Alice Egerton, George Vamvakas and 3 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Sameer Jauhar *Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK. Sameer.jauhar@kcl.ac.uk.ORCID 0000-0002-3878-3659
Robert A McCutcheon *Department of Psychiatry, University of Oxford, Oxford, UK.ORCID 0000-0003-1102-2566
Mattia VeroneseCentre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.ORCID 0000-0003-3562-0683
Faith BorganDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.ORCID 0000-0002-5017-5226
Matthew NourMax Planck UCL Centre for Computational Psychiatry and Ageing Research, Berlin, Germany.
Maria RogdakiDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.ORCID 0000-0003-2685-1789
Fiona PepperDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
James M StoneDepartment of Neuroscience and Imaging, University of Sussex, Brighton and Hove, UK.ORCID 0000-0003-3051-0135
Alice EgertonDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.ORCID 0000-0003-2939-064X
George VamvakasDepartment of Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
Federico TurkheimerCentre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.ORCID 0000-0002-3766-3815
Philip K McGuireDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID 0000-0003-4381-0532
Oliver D HowesDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
King's College London · GBWellcome Centre for Human Neuroimaging · GBMax Planck Institute for Biology of Ageing · DEUniversity of Oxford · GBUniversity of Sussex · GB

Funding

Medical Research Council MC_U120097115Medical Research Council MR/V013734/1Medical Research Council MR/W005557/1
6 · The paper itself

Abstract

The neuromodulator dopamine and excitatory neurotransmitter glutamate have both been implicated in the pathogenesis of psychosis, and dopamine antagonists remain the predominant treatment for psychotic disorders. To date no study has measured the effect of antipsychotics on both of these indices together, in the same population of people with psychosis. Striatal dopamine synthesis capacity (Ki

Indexed as

Antipsychotic AgentsPsychotic DisordersCorpus StriatumDopamineGlutamic AcidGyrus CinguliHumansPositron-Emission TomographyAntipsychotic AgentsDopamineGlutamic Acid

Identifiers

PMID37253720
PMCPMC10229638
OpenAlexW4378781924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.